Summit Trail Advisors, LLC Aerie Pharmaceuticals Inc Transaction History

Summit Trail Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$33.0 - $60.04 $120,450 - $219,146	-3,650 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $51,938 - $68,357	925 Added 33.94%	3,650 $225,000
Q2 2018 Aug 10, 2018	SELL	$47.85 - $70.45 $440,076 - $647,928	-9,197 Reduced 77.14%	2,725 $184,000
Q1 2018 May 22, 2018	SELL	$51.15 - $61.0 $21.9 Million - $26.1 Million	-427,989 Reduced 97.29%	11,922 $440,000
Q1 2018 May 21, 2018	BUY	$51.15 - $61.0 $22 Million - $26.2 Million	429,272 Added 4034.89%	439,911 $440,000
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $540,993 - $692,598	10,639	10,639 $596,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.